Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
by Radboud J. Duintjer Tebbens and Kimberly M. Thompson, Medical Decision Making Policy & Practice 2017; doi:10.1177/2381468317697002 (published on-line March 1, 2017).

Answers to frequently asked questions

What are the study’s main findings?
What are the study’s main recommendations?
Background on polio

What are the study’s main findings?

What are the study’s main recommendations?